JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

News

Home |
News

All Categories

12 Mar

ImmunoPrecise Announces the Launch of PolyTope mAb Therapy™ to Tackle Coronavirus Pandemic.

New Approach Entails a Defined Antibody Combination Targeting Multiple Epitopes and Mechanisms of Viral Evasion.
...
READ MORE
10 Mar

ImmunoPrecise Reports Record Quarterly and Nine Month Revenue and Positive Adjusted EBITDA

Revenue outlook is positive for the fourth quarter.
...
READ MORE
06 Mar

ImmunoPrecise Announces Debt Settlement of Previously Issued Debentures

The purpose is to reduce the ongoing debt obligations.
...
READ MORE
02 Mar

ImmunoPrecise Announces Artificial Intelligence Collaboration with EVQLV to Accelerate Vaccine and Antibody Discovery for SARS-CoV-2 Coronavirus

EVQLV can filter antibody candidates with a higher probability of success against the SARS-CoV-2 Coronavirus.
...
READ MORE
20 Feb

ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program

IPA to develop innovative vaccines and coronavirus-neutralizing antibodies against SARS-CoV-2.
...
READ MORE
20 Jan

ImmunoPrecise integrates SGI-DNA's benchtop automated DNA printer to accelerate antibody discovery and manufacturing services

The BioXp 3200 will reduce the turnaround time for cloning activities in discovery and manufacturing projects
...
READ MORE